| Drug Name: | Fluvoxamine (54739-18-3) |
|---|---|
| PubChem ID: | 5324346 |
| SMILES: | COCCCC/C(=NOCCN)/C1=CC=C(C=C1)C(F)(F)F |
| InchiKey: | CJOFXWAVKWHTFT-XSFVSMFZSA-N |
| Therapeutic Category: | Anti-Anxiety Agents, Antidepressive Agents, Central Nervous System Agents, Central Nervous System Depressants, Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Enzyme Inhibitors, Membrane Transport Modulators, Neurotransmitter Agents, Neurotransmitter Uptake Inhibitors, Psychotropic Drugs, Serotonin Agents, Serotonin Uptake Inhibitors, Tranquilizing Agents |
| Molecular Weight (dalton) | : | 318.339 |
| LogP | : | 3.2015 |
| Ring Count | : | 1 |
| Hydrogen Bond Acceptor Count | : | 4 |
| Hydrogen Bond Donor Count | : | 1 |
| Total Polar Surface Area | : | 56.84 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|---|---|---|---|
| Selegiline (14611-51-9) | Cns Toxicity | Synergistic | Not understood | Movement Disorders : A Brief Guide in Medication Management |
| Selegiline (14611-51-9) | Increased Muscle Tone | Synergistic | Not understood | Movement Disorders : A Brief Guide in Medication Management |
| Selegiline (14611-51-9) | Myoclonus | Synergistic | Not understood | Movement Disorders : A Brief Guide in Medication Management |
| Selegiline (14611-51-9) | Shivering | Synergistic | Not understood | Movement Disorders : A Brief Guide in Medication Management |
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|---|---|---|
| Toxicity And Inefficacy | CYP2D6 (P10635) | Toxicity in poor metabolisers@ inefficacy in ultrarapid metabolisers. [ ADR Type 3 ] | Drugs in special patient groups: clinical importance of genomics in drug effects In: Carruthers GS, Hoffmann BB,Melmon KL, Nierenberg DW |
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category